BMO Capital lifts Hanover Insurance stock target to $189

Published 11/02/2025, 14:10
BMO Capital lifts Hanover Insurance stock target to $189

On Tuesday, BMO Capital Markets updated their financial outlook for The Hanover Insurance Group (NYSE:THG), increasing the price target slightly to $189 from $188, while maintaining an Outperform rating on the company’s shares. Currently trading at $161.97 and near its 52-week high of $166.98, the stock has shown strong momentum with a 25.93% return over the past year. The adjustment reflects a positive view on the company’s ability to improve its underlying loss ratio, particularly within the personal lines sector, such as homeowners insurance. However, the firm anticipates some margin deterioration in the commercial segment. According to InvestingPro analysis, the stock appears undervalued based on its proprietary Fair Value model.

Analysts at BMO Capital expect The Hanover Insurance Group to experience a 1% growth through 2026. This forecast is slightly higher than the consensus and The Hanover’s own guidance. The company has demonstrated steady performance with revenue growth of 4.07% in the last twelve months and maintains a strong dividend track record, having paid dividends consistently for 20 consecutive years. The analysts believe that the company will achieve a modestly better underlying loss ratio, which is offset by a higher expense ratio due to profit commissions and a 20 basis point increase in catastrophe losses.

The new price target of $189 is based on an 11.2 times price-to-earnings (P/E) multiple of the firm’s 2026 operating earnings per share (EPS) estimate, which is $16.83, or 7% above the consensus. Currently trading at a P/E ratio of 13.66x, with analyst targets ranging from $170 to $190, the stock shows potential for growth. This P/E multiple is 9% below the historical levels for The Hanover Insurance Group. Additionally, BMO Capital’s target reflects a 2.1 times price-to-book value (P/BV) excluding accumulated other comprehensive income (AOCI), which is 35% above the historical average for the insurer. For a deeper understanding of THG’s valuation metrics and growth potential, InvestingPro subscribers can access comprehensive research reports and additional financial insights.

The Hanover Insurance Group’s stock price adjustment follows a comprehensive analysis by BMO Capital, which took into account various factors including growth projections, expense ratios, and potential catastrophe losses. The firm’s analysts have provided a detailed rationale for their outlook, emphasizing the balance between improved loss ratios in certain lines and expected challenges in others. With an overall "GOOD" financial health score from InvestingPro, the company demonstrates solid fundamentals and promising growth prospects.

In other recent news, The Hanover Insurance Group has been the subject of revised price targets by analysts at Keefe, Bruyette & Woods and Oppenheimer. Following Hanover’s fourth-quarter earnings report, Keefe, Bruyette & Woods analyst Meyer Shields raised the price target to $179, citing the insurance company’s future earnings potential. Shields’ revised estimates for the 2025 and 2026 earnings per share (EPS) were raised due to expectations of accelerated premium and net investment income growth, among other factors.

Simultaneously, Oppenheimer analysts increased their price target for Hanover to $185 after the company’s fourth-quarter results and 2025 guidance surpassed expectations. The analysts projected double-digit EPS growth in 2025 and 2026, driven by increased net investment income and improving underwriting margins.

These recent developments come after Hanover reported fourth-quarter earnings that exceeded analyst estimates, with operating earnings of $5.32 per share and a revenue increase of 7.4% year-over-year. The company’s combined ratio improved to 89.2%, indicating better profitability, and net investment income jumped 23.4% to $100.7 million. These positive results underscore the analysts’ optimism about Hanover’s future performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.